Hydration Pharmaceuticals Company LimitedASX: HPC

Q3 FY26 Quarterly Activities Report (App 4C)

· Issued by Hydration Pharmaceuticals Company Limited via ASX

Filed with ASX · · 9 pages · English

Summary by 6ix AI

The report highlights that Hydralyte LLC achieved its first monthly profit and significantly reduced its quarterly operating loss compared to the previous year. The company also noted a substantial decrease in operating expenses and improved advertising efficiency, despite a decline in revenue due to stock shortages. The cash position at the end of the quarter was reported, along with plans for a rights issue to support ongoing operations and growth.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/q3-fy26-quarterly-activities-report-app-4c-1

Release

743 Prospect Street La Jolla CA 92037 Company Announcement — ASX: HPC 30 October 2026 Quarterly Activities Report and Appendix 4C — quarter ended 30 September 2026 Hydralyte LLC records maiden monthly profit; quarterly operating loss cut 85% HIGHLIGHTS • Operating loss down 85%: Hydralyte LLC...

Hydration Pharmaceuticals Company Limited on 6ix

Story so far

Earlier from Hydration Pharmaceuticals

Later from Hydration Pharmaceuticals

All Hydration Pharmaceuticals news releases